{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:46:45Z","timestamp":1790200005343,"version":"4.1.0"},"reference-count":126,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Invasive aspergillosis (IA) is a fungal infection, which has traditionally been associated with neutropenia and immunosuppressive therapies. Our understanding of invasive aspergillosis has been evolving and, in the past few decades, IA among ICU patients has been recognized as a common infection and has become more widely recognized. The diagnosis and management of invasive aspergillosis in the ICU is particularly challenging, due to the unstable clinical condition of the patients, lack of diagnostic markers, increased risk of further clinical deterioration, multiple comorbidities, and a need for early assessment and treatment. In this article, we will discuss the challenges and pitfalls of the diagnosis and management of invasive aspergillosis in an ICU setting, along with a review of the current literature that is pertinent and specific to this population.<\/jats:p>","DOI":"10.3390\/jof11010070","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T03:33:02Z","timestamp":1737084782000},"page":"70","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Invasive Aspergillosis in the Intensive Care Unit"],"prefix":"10.3390","volume":"11","author":[{"given":"Anna","family":"Zubovskaia","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5774-819X","authenticated-orcid":false,"given":"Jose A.","family":"Vazquez","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/apm.13316","article-title":"Invasive pulmonary aspergillosis in the intensive care unit: Current challenges and best practices","volume":"131","author":"Gaffney","year":"2023","journal-title":"APMIS"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/myc.13274","article-title":"Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches","volume":"64","author":"Jenks","year":"2021","journal-title":"Mycoses"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e3606","DOI":"10.1093\/cid\/ciaa1065","article-title":"Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study","volume":"73","author":"Bartoletti","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e1634","DOI":"10.1093\/cid\/ciaa1298","article-title":"A National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit","volume":"73","author":"White","year":"2021","journal-title":"Clin Infect Dis."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Wang, Y., Yao, Y., Zhang, Q., Chen, H., He, Y., and Hu, K. (2024). Clinical courses and outcomes of COVID-19 associated pulmonary aspergillosis in 168 patients with the SARS-CoV-2 omicron variant. BMC Infect. Dis., 24.","DOI":"10.1186\/s12879-023-08971-w"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Baddley, J.W., Stephens, J.M., Ji, X., Gao, X., Schlamm, H.T., and Tarallo, M. (2013). Aspergillosis in Intensive Care Unit (ICU) patients: Epidemiology and economic outcomes. BMC Infect. Dis., 13.","DOI":"10.1186\/1471-2334-13-29"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/518852","article-title":"Invasive aspergillosis in the intensive care unit","volume":"45","author":"Meersseman","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc4823","article-title":"Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients","volume":"10","author":"Vandewoude","year":"2006","journal-title":"Crit. Care"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"Meersseman","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","article-title":"Epidemiology of invasive aspergillosis in critically ill patients: Clinical presentation, underlying conditions, and outcomes","volume":"19","author":"Taccone","year":"2015","journal-title":"Crit. Care"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1164\/rccm.201612-2540LE","article-title":"Influenza-Associated Aspergillosis in Critically Ill Patients","volume":"196","author":"Kolwijck","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/myc.13434","article-title":"COVID-19-associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID-19 patients","volume":"65","year":"2022","journal-title":"Mycoses"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"ofab091","DOI":"10.1093\/ofid\/ofab091","article-title":"Invasive Aspergillosis After Influenza and Other Viral Respiratory Infections Among Intensive Care Unit Patients in a Commercially Insured Population in the United States, 2013-2018","volume":"8","author":"Toda","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/cid\/ciaa007","article-title":"High Rates of Influenza-Associated Invasive Pulmonary Aspergillosis May Not Be Universal: A Retrospective Cohort Study from Alberta, Canada","volume":"71","author":"Schwartz","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e13059","DOI":"10.1111\/irv.13059","article-title":"Higher risk for influenza-associated pulmonary aspergillosis (IAPA) in asthmatic patients: A Swiss multicenter cohort study on IAPA in critically ill influenza patients","volume":"17","author":"Waldeck","year":"2023","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"ofad155","DOI":"10.1093\/ofid\/ofad155","article-title":"Coronavirus Disease 2019\u2013Associated Pulmonary Aspergillosis: A Noninvasive Screening Model for Additional Diagnostics","volume":"10","author":"Permpalung","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmi.2021.08.014","article-title":"Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology","volume":"28","author":"Prattes","year":"2022","journal-title":"Clin Microbiol Infect."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ccm.2009.03.001","article-title":"Fungal infections in hematopoietic stem cell transplantation and solid-organ transplantation--focus on aspergillosis","volume":"30","author":"Nucci","year":"2009","journal-title":"Clin. Chest Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Townsend, L., and Martin-Loeches, I. (2022). Invasive Aspergillosis in the Intensive Care Unit. Diagnostics, 12.","DOI":"10.3390\/diagnostics12112712"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13613-021-00827-3","article-title":"New clinical algorithm including fungal biomarkers to better diagnose probable invasive pulmonary aspergillosis in ICU","volume":"11","author":"Hamam","year":"2021","journal-title":"Ann. Intensive Care"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.burns.2008.04.007","article-title":"Incidence of systemic fungal infection and related mortality following severe burns","volume":"34","author":"Murray","year":"2008","journal-title":"Burns"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: A retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/crj.12995","article-title":"Invasive pulmonary aspergillosis in patients with influenza infection: A retrospective study and review of the literature","volume":"13","author":"Huang","year":"2019","journal-title":"Clin. Respir. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1080\/13693780600897989","article-title":"Interactions of Aspergillus fumigatus with vascular endothelial cells","volume":"44","author":"Kamai","year":"2006","journal-title":"Med. Mycol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S2213-2600(24)00151-6","article-title":"Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients","volume":"12","author":"Feys","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: The 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/thorax-2023-220002","article-title":"COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: A prospective, multicentre UK study","volume":"79","author":"Hurt","year":"2023","journal-title":"Thorax"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S2666-5247(21)00091-4","article-title":"Invasive mould disease in fatal COVID-19: A systematic review of autopsies","volume":"2","author":"Kula","year":"2021","journal-title":"Lancet Microbe"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"ofae406","DOI":"10.1093\/ofid\/ofae406","article-title":"Predicting COVID 19-Associated Pulmonary Aspergillosis Risk in Low- and Middle-Income Countries: A Matched Case-Control Study","volume":"11","author":"Moni","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Iacovelli, A., Oliva, A., Mirabelli, F.M., Giannone, S., Laguardia, M., Morviducci, M., Nicolardi, M.L., Repaci, E., Sanzari, M.T., and Leanza, C. (2024). Risk factors for COVID-19 associated pulmonary aspergillosis and outcomes in patients with acute respiratory failure in a respiratory sub-intensive care unit. BMC Infect. Dis., 24.","DOI":"10.1186\/s12879-024-09283-3"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S2213-2600(23)00408-3","article-title":"Risk factors for COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis","volume":"12","author":"Gioia","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: A 6-year survey","volume":"43","author":"Cornillet","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Liu, L., Gu, Y., Wang, Y., Shen, K., and Su, X. (2021). The Clinical Characteristics of Patients With Nonneutropenic Invasive Pulmonary Aspergillosis. Front. Med., 8.","DOI":"10.3389\/fmed.2021.631461"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/CMR.00053-10","article-title":"Histopathologic diagnosis of fungal infections in the 21st century","volume":"24","author":"Guarner","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","article-title":"Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: Incidence, risk factors, and outcome","volume":"16","author":"Guinea","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"352","DOI":"10.21037\/atm.2016.08.06","article-title":"Improving diagnostic accuracy for invasive pulmonary aspergillosis in the intensive care unit","volume":"4","author":"Kaziani","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"106159","DOI":"10.1016\/j.jinf.2024.106159","article-title":"Performance of the galactomannan test for the diagnosis of invasive pulmonary aspergillosis using non-invasive proximal airway samples","volume":"88","author":"Chun","year":"2024","journal-title":"J. Infect."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12185-009-0429-8","article-title":"Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients","volume":"90","author":"Kimura","year":"2009","journal-title":"Int. J. Hematol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2011-04-351601","article-title":"The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies","volume":"119","author":"Bergeron","year":"2012","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1086\/647935","article-title":"Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases","volume":"49","author":"Maertens","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/422009","article-title":"Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: Variables that affect performance","volume":"190","author":"Marr","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/00365541003602064","article-title":"False-positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics","volume":"42","author":"Boonsarngsuk","year":"2010","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_47","first-page":"411","article-title":"False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation","volume":"61","author":"Kanda","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10096-007-0437-7","article-title":"Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay","volume":"27","author":"Wheat","year":"2008","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_49","first-page":"CD009551","article-title":"Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people","volume":"9","author":"Cruciani","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Egger, M., Jenks, J.D., Hoenigl, M., and Prattes, J. (2020). Blood Aspergillus PCR: The Good, the Bad, and the Ugly. J. Fungi, 6.","DOI":"10.3390\/jof6010018"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcrc.2018.07.001","article-title":"Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study","volume":"47","author":"Boch","year":"2018","journal-title":"J. Crit. Care."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Imbert, S., Meyer, I., Palous, M., Brossas, J.Y., Uzunov, M., Touafek, F., Gay, F., Trosini-Desert, V., and Fekkar, A. (2018). Aspergillus PCR in Bronchoalveolar Lavage Fluid for the Diagnosis and Prognosis of Aspergillosis in Patients With Hematological and Non-hematological Conditions. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.01877"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/mmy\/myz002","article-title":"Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: The need for a combined use with galactomannan","volume":"57","author":"Mikulska","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/myc.13428","article-title":"Aspergillus-PCR in bronchoalveolar lavage\u2014Diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients","volume":"65","author":"Mikulska","year":"2022","journal-title":"Mycoses"},{"key":"ref_55","first-page":"528","article-title":"Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis","volume":"55","author":"Eigl","year":"2017","journal-title":"Med. Mycol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"ofae425","DOI":"10.1093\/ofid\/ofae425","article-title":"Clinical Utility of Plasma Microbial Cell-Free DNA Sequencing Among Immunocompromised Patients With Pneumonia","volume":"11","author":"Madut","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"ofae252","DOI":"10.1093\/ofid\/ofae252","article-title":"Diagnostic Value of Microbial Cell-free DNA Sequencing for Suspected Invasive Fungal Infections: A Retrospective Multicenter Cohort Study","volume":"11","author":"Huygens","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/cid\/ciad420","article-title":"Superior Accuracy of Aspergillus Plasma Cell-Free DNA Polymerase Chain Reaction Over Serum Galactomannan for the Diagnosis of Invasive Aspergillosis","volume":"77","author":"Mah","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Cai, X., Sun, C., Zhong, H., Cai, Y., Cao, M., Wang, L., Sun, W., Tao, Y., Ma, G., and Huang, B. (2024). The value of metagenomic next-generation sequencing with different nucleic acid extracting methods of cell-free DNA or whole-cell DNA in the diagnosis of non-neutropenic pulmonary aspergillosis. Front. Cell Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1398190"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Hoenigl, M., Egger, M., Price, J., Krause, R., Prattes, J., and White, P.L. (2023). Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis. J. Clin. Microbiol., 61.","DOI":"10.1128\/jcm.01859-22"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Liu, Z., Chen, H., Chen, D., Wu, X., Xu, H., Chen, P., Wang, R., and Chen, Y. (2024). Metagenomic next-generation sequencing for the diagnosis of invasive pulmonary aspergillosis in type 2 diabetes mellitus patients. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-67174-8"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Bao, S., Song, H., Chen, Y., Zhong, C., and Tang, H. (2022). Metagenomic next-generation sequencing for the diagnosis of pulmonary aspergillosis in non-neutropenic patients: A retrospective study. Front. Cell Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.925982"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/infdis\/jiad213","article-title":"Utility of Plasma Microbial Cell-Free DNA Whole-Genome Sequencing for Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancy or COVID-19","volume":"228","author":"Lee","year":"2023","journal-title":"J. Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jinf.2018.10.014","article-title":"Bronchoalveolar lavage Aspergillus Galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test for diagnosis of invasive pulmonary Aspergillosis in patients with hematological malignancies","volume":"78","author":"Jenks","year":"2019","journal-title":"J. Infect."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1055\/s-0035-1562892","article-title":"Role of Non-Culture-Based Tests, with an Emphasis on Galactomannan Testing for the Diagnosis of Invasive Aspergillosis","volume":"36","author":"Miceli","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.jfma.2022.04.011","article-title":"Comparison of a novel lateral-flow device to galactomannan assay at different time periods for detections of invasive aspergillosis","volume":"121","author":"Hsiao","year":"2022","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12281-017-0275-8","article-title":"Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status","volume":"11","author":"Heldt","year":"2017","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1186\/s13054-020-03367-7","article-title":"Point of care aspergillus testing in intensive care patients","volume":"24","author":"Mercier","year":"2020","journal-title":"Crit. Care"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1111\/liv.15648","article-title":"Fungal translocation measured by serum 1,3-\u00df-D-glucan correlates with severity and outcome of liver cirrhosis-A pilot study","volume":"43","author":"Egger","year":"2023","journal-title":"Liver Int."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Hoenigl, M., P\u00e9rez-Santiago, J., Nakazawa, M., de Oliveira, M.F., Zhang, Y., Finkelman, M.A., Letendre, S., Smith, D., and Gianella, S. (2016). (1\u21923)-\u03b2-d-Glucan: A Biomarker for Microbial Translocation in Individuals with Acute or Early HIV Infection?. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00404"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/cid\/ciz215","article-title":"Fungal Translocation: A Driving Force Behind the Occurrence of Non-AIDS Events?","volume":"70","author":"Hoenigl","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1080\/13693780802308454","article-title":"Role of (1-->3)-beta-D-glucan in the diagnosis of invasive aspergillosis","volume":"47","author":"Marty","year":"2009","journal-title":"Med. Mycol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2214\/ajr.150.5.1015","article-title":"CT of invasive pulmonary aspergillosis","volume":"150","author":"Kuhlman","year":"1988","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/cid\/ciaa1855","article-title":"Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC\/MSGERC","volume":"72","author":"Alexander","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/509917","article-title":"Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign","volume":"44","author":"Greene","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1080\/13693780500064771","article-title":"The radiological spectrum of pulmonary aspergillosis","volume":"43","author":"Greene","year":"2005","journal-title":"Med. Mycol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.medmal.2013.11.006","article-title":"Diagnosis of invasive pulmonary aspergillosis: Updates and recommendations","volume":"44","author":"Desoubeaux","year":"2014","journal-title":"Med. Mal. Infect."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jinf.2011.08.007","article-title":"Computed tomography findings in invasive pulmonary aspergillosis in non-neutropenic transplant recipients and neutropenic patients, and their prognostic value","volume":"63","author":"Park","year":"2011","journal-title":"J. Infect."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1259\/bjr\/49174919","article-title":"Invasive pulmonary aspergillosis: Frequency and meaning of the \u201chypodense sign\u201d on unenhanced, C","volume":"78","author":"Horger","year":"2005","journal-title":"T. Br. J. Radiol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Ankrah, A.O., Creemers-Schild, D., de Keizer, B., Klein, H.C., Dierckx, R.A.J.O., Kwee, T.C., Span, L.F.R., de Jong, P.A., Sathekge, M.M., and Glaudemans, A.W.J.M. (2021). The Added Value of [18F]FDG PET\/CT in the Management of Invasive Fungal Infections. Diagnostics, 11.","DOI":"10.3390\/diagnostics11010137"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"jiae409","DOI":"10.1093\/infdis\/jiae409","article-title":"Role of serial fluorodeoxyglucose positron emission tomography-computed tomography (18FDG-PET-CT) in assessing treatment response in treatment na\u00efve chronic pulmonary aspergillosis subjects","volume":"19","author":"Sehgal","year":"2024","journal-title":"J. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2214\/AJR.13.11712","article-title":"Potential role of 18F-FDG PET\/CT in patients with fungal infections","volume":"203","author":"Sharma","year":"2014","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1469-0691.2010.03301.x","article-title":"Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections","volume":"17","author":"Hot","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00259-018-4192-z","article-title":"Role of FDG PET\/CT in monitoring treatment response in patients with invasive fungal infections","volume":"46","author":"Ankrah","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s40336-022-00497-6","article-title":"Heterogeneous imaging features of Aspergillosis at 18F-FDG PET\/CT","volume":"10","author":"Altini","year":"2022","journal-title":"Clin. Transl. Imaging"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): A phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: A randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1093\/jac\/dkw276","article-title":"Dose optimization of voriconazole\/anidulafungin combination against Aspergillus fumigatus using an in vitro pharmacokinetic\/pharmacodynamic model and response surface analysis: Clinical implications for azole-resistant aspergillosis","volume":"71","author":"Siopi","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijid.2014.07.007","article-title":"Salvage combination antifungal therapy for acute invasive aspergillosis may improve outcomes: A systematic review and meta-analysis","volume":"28","author":"Panackal","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijantimicag.2014.08.012","article-title":"Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies","volume":"45","author":"Raad","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/21505594.2016.1196300","article-title":"Combinatorial strategies for combating invasive fungal infections","volume":"8","author":"Spitzer","year":"2017","journal-title":"Virulence"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/423381","article-title":"Caspofungin Salvage Aspergillosis Study Group. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy","volume":"39","author":"Maertens","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.2147\/IDR.S372546","article-title":"Salvage Treatment for Invasive Aspergillosis and Mucormycosis: Challenges, Recommendations and Future Considerations","volume":"16","author":"Egger","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3111\/13696998.2011.564246","article-title":"US hospital database analysis of invasive aspergillosis in the chronic obstructive pulmonary disease non-traditional host","volume":"14","author":"Patel","year":"2011","journal-title":"J. Med. Econ."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/lt.24032","article-title":"Invasive aspergillosis in liver transplant recipients: Epidemiology, clinical characteristics, treatment, and outcomes in 116 cases","volume":"21","author":"Barchiesi","year":"2015","journal-title":"Liver Transpl."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12281-023-00459-z","article-title":"Invasive Aspergillosis and the Impact of Azole-resistance","volume":"17","author":"Bosetti","year":"2023","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"De Francesco, M.A. (2023). Drug-Resistant Aspergillus spp.: A Literature Review of Its Resistance Mechanisms and Its Prevalence in Europe. Pathogens., 12.","DOI":"10.3390\/pathogens12111305"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.3109\/13693786.2010.499916","article-title":"Aspergillus species intrinsically resistant to antifungal agents","volume":"49","author":"Warris","year":"2011","journal-title":"Med. Mycol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/infdis\/jix210","article-title":"Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment","volume":"216","author":"Chowdhary","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/cid\/ciy859","article-title":"Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study","volume":"68","author":"Lestrade","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/jac\/dkae037","article-title":"Lower blood levels of isavuconazole in critically ill patients compared with other populations: Possible need for therapeutic drug monitoring","volume":"79","author":"Mikulska","year":"2024","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Risum, M., Vestergaard, M.B., Weinreich, U.M., Helleberg, M., Vissing, N.H., and J\u00f8rgensen, R. (2021). Therapeutic Drug Monitoring of Isavuconazole: Serum Concentration Variability and Success Rates for Reaching Target in Comparison with Voriconazole. Antibiotics, 10.","DOI":"10.3390\/antibiotics10050487"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"ofaa016","DOI":"10.1093\/ofid\/ofaa016","article-title":"Hope on the Horizon: Novel Fungal Treatments in Development","volume":"7","author":"Rauseo","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s40265-021-01611-0","article-title":"The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin","volume":"81","author":"Hoenigl","year":"2021","journal-title":"Drugs"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jgar.2021.04.012","article-title":"Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018-2019)","volume":"26","author":"Pfaller","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e0162322","DOI":"10.1128\/aac.01623-22","article-title":"Safety and Pharmacokinetics of Intravenous and Oral Fosmanogepix, a First-in-Class Antifungal Agent, in Healthy Volunteers","volume":"67","author":"Hodges","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e0220621","DOI":"10.1128\/aac.02206-21","article-title":"Successful Treatment of Disseminated Disease Due to Highly Resistant Aspergillus calidoustus with a Novel Antifungal Therapy","volume":"66","author":"Camargo","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e0236821","DOI":"10.1128\/aac.02368-21","article-title":"Case Commentary: Long-Term Fosmanogepix Use in a Transplant Recipient with Disseminated Aspergillosis Caused by Azole-Resistant Aspergillus calidoustus","volume":"66","author":"Kline","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Shaw, K.J., and Ibrahim, A.S. (2020). Fosmanogepix: A Review of the First-in-Class Broad Spectrum Agent for the Treatment of Invasive Fungal Infections. J. Fungi, 6.","DOI":"10.3390\/jof6040239"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e0038022","DOI":"10.1128\/aac.00380-22","article-title":"The Combination Treatment of Fosmanogepix and Liposomal Amphotericin B Is Superior to Monotherapy in Treating Experimental Invasive Mold Infections","volume":"66","author":"Gebremariam","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e00690","DOI":"10.1002\/prp2.690","article-title":"Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent","volume":"9","author":"Cass","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.cmi.2022.05.013","article-title":"In vitro activity of olorofim against Aspergillus fumigatus sensu lato clinical isolates: Activity is retained against isolates showing resistance to azoles and\/or amphotericin B","volume":"28","author":"Escribano","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Feuss, A., Bougnoux, M.E., and Dannaoui, E. (2024). The Role of Olorofim in the Treatment of Filamentous Fungal Infections: A Review of In Vitro and In Vivo Studies. J. Fungi, 10.","DOI":"10.3390\/jof10050345"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Angulo, D.A., Alexander, B., Rautemaa-Richardson, R., Alastruey-Izquierdo, A., Hoenigl, M., Ibrahim, A.S., Ghannoum, M.A., King, T.R., Azie, N.E., and Walsh, T.J. (2022). Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections. J. Fungi, 8.","DOI":"10.3390\/jof8111121"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e00244-18","DOI":"10.1128\/AAC.00244-18","article-title":"Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis","volume":"62","author":"Ghannoum","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e02429-19","DOI":"10.1128\/AAC.02429-19","article-title":"Combination Therapy with Ibrexafungerp (Formerly SCY-078), a First-in-Class Triterpenoid Inhibitor of (1\u21923)-\u03b2-d-Glucan Synthesis, and Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis","volume":"64","author":"Petraitis","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/jac\/dky280","article-title":"Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species","volume":"73","author":"Wiederhold","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1093\/jac\/dkw214","article-title":"Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates","volume":"71","author":"Pfaller","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e01165-19","DOI":"10.1128\/AAC.01165-19","article-title":"Extended-Interval Dosing of Rezafungin against Azole-Resistant Aspergillus fumigatus","volume":"63","author":"Wiederhold","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"101310","DOI":"10.1016\/j.conctc.2024.101310","article-title":"Study protocol: A randomized, double-blind, placebo-controlled trial of isavuconazole prophylaxis for the prevention of COVID-19-associated pulmonary aspergillosis","volume":"39","author":"Jenks","year":"2024","journal-title":"Contemp. Clin. Trials Commun."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13054-021-03753-9","article-title":"Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: An observational study","volume":"25","author":"Hatzl","year":"2021","journal-title":"Crit. Care"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00134-021-06431-0","article-title":"Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): A randomised, open-label, proof-of-concept trial","volume":"47","author":"Vanderbeke","year":"2021","journal-title":"Intensive Care Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e0696","DOI":"10.1097\/CCE.0000000000000696","article-title":"Nebulized Amphotericin B in Mechanically Ventilated COVID-19 Patients to Prevent Invasive Pulmonary Aspergillosis: A Retrospective Cohort Study","volume":"4","author":"Melchers","year":"2022","journal-title":"Crit. Care Explor."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13054-021-03728-w","article-title":"Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis\/aspergillus tracheobronchitis","volume":"25","author":"Rutsaert","year":"2021","journal-title":"Crit. Care"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/11\/1\/70\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:30:17Z","timestamp":1759919417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/11\/1\/70"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":126,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["jof11010070"],"URL":"https:\/\/doi.org\/10.3390\/jof11010070","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]}}}